Health-related quality of life of people with epilepsy compared with a general reference population: A Tunisian study

Epilepsia

Volumn 45, Issue 7, 2004, Pages 838-843

  Mrabet, Hela ^a   Mrabet, Amel ^a   Zouari, Bechir ^b   Ghachem, Rim ^c  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c RAZI HOSPITAL   (Tunisia)

Author keywords

Cross cultural differences; Epilepsy; Health related quality of life; SF 36

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; DATA ANALYSIS; DEMOGRAPHY; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTPATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIGION; RISK FACTOR; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SOCIAL STATUS; SOCIOECONOMICS; SYMPTOMATOLOGY; TUNISIA;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTICONVULSANTS; CASE-CONTROL STUDIES; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; EPILEPSY; ETHNIC GROUPS; EUROPE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TUNISIA; VALPROIC ACID;

EID: 3042859094     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.56903.x     Document Type: Article

References (25)

1. Reynolds EH. The ILAE/IBE/WHO epilepsy global campaign history: International League Against Epilepsy: International Bureau for Epilepsy. Epilepsia 2002;43:9-11.
2. Meinardi H, Scott RA, Reis R, et al. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001;42:136-49.
3. Stavem K, Loge JH, Kaasa S. Health status of people with epilepsy compared with a general reference population. Epilepsia 2000;41:85-90.
4. Buck D, Jacoby A, Baker GA, et al. Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 1999;8:675-85.
5. Leidy NK, Elixhauser A, Vickrey B, et al. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999;53:162-66.
6. Baker GA, Hesdon B, Marson AG. Quality-of-life and behavioral outcome measures in randomized controlled trials of anti-epileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 2000;41:1357-63.
7. Baker GA, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res 1998;30:231-40.
8. Attia Romdhane N, Mrabet Bahri A, Ben Hamida M. Prevalence of epilepsy in Kelibia, Tunisia. Epilepsia 1993;34:1028-32.
9. Ministère du plan et du développement rural. Résultats du recensement de la population et de l'habitat 1994. Tunis: Institut Natl la Stat Tunis, 1997.
10. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.
11. Buck D, Baker GA, Jacoby A, et al. Patients' experiences of injury as a result of epilepsy. Epilepsia 1997;38:439-44.
12. Ley P. Improving patient's understanding, recall, satisfaction and compliance. In: Broome AK, ed. Health psychology: process and applications. London Chapman & Hall, 1987:133.
13. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures: Epilepsia 1981;22:489-501.
14. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
15. Hays R, Sherbourne C, Mazel R. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
16. Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
17. Jacoby A, Baker GA, Steen N. The SF-36 as a health status measure for epilepsy: a psychometric assessment. Qual Life Res 1999;8:351-64.
18. Freeman JA, Hobart JC, Langdon DW, et al. Clinical appropriateness: a key factor in outcome measure selection: the 36-item short form health survey in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:150-6.
19. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for assessing the impact of epilepsy and anti-epileptic drug therapy on patients' health-related quality of life. Qual Life Res 1995;4:115-34.
20. Coons SJ, Alabdulmohsin SA, Draugalis JR, et al. Reliability of an Arabic version of the RAND-36 Health Survey and its equivalence to the US-English version. Med Care 1998;36:428-32.
21. Baker GA. Assessment of quality of life in people with epilepsy: some practical implications. Epilepsia 2001;42:66-9.
22. Buck D, Jacoby A, Baker GA, et al. Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 1999;8:675-85.
23. Cascino GD. Video-EEG monitoring in adults. Epilepsia 2002;43:80-93.
24. Birbeck GL, Kalichi EM. The functional status of people with epilepsy in rural sub-Saharan Africa. J Neurol Sci 2003;15:65-8.
25. Mielke J, Sebit M, Adamolekun B, et al. The impact of epilepsy on the quality of life of people with epilepsy in Zimbabwe: a pilot study. Seizure 2000;9:259-64.